Carregant...
Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy
BACKGROUND: This review update has been managed by both the Childhood Cancer and Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Groups. The use of anthracycline chemotherapy is limited by the occurrence of cardiotoxicity. To prevent this cardiotoxicity, different anthracycline dosage sche...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2016
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457744/ https://ncbi.nlm.nih.gov/pubmed/26938118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005008.pub4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|